$ 357.00 <%= Resources.Global.txtDown %>
Updated 14:59:59
Change % -0.32% Stock price decreasing
Change -1.16 Stock price decreasing
Volume 33,950
High $ 357.73
Low $ 353.71
Open $ 356.32
ISIN
Prev close $ 358.16
# of shares 147.00M
Market cap 52,479M USD
Intraday

Illumina Inc
Market is open (until 21:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  357.00 2.8% Stock price increasing 4.8% Stock price increasing 26.3% Stock price increasing 51.7% Stock price increasing 77.3% Stock price increasing
Powered by TradingView

News about Illumina Inc

  • English
  • Regulatory news

Company profile

Illumina is a major player in life science tools for analyzing genetic material. Revenue from microarray and genome sequencing machines and disposables make up most of the company's revenue, but approximately 18% of the company's sales come from testing services. Essentially all of Illumina's growth stems from the company's genome sequencing products, which include the company's high-throughput NovaSeq and HiSeq instruments in addition to its benchtop NextSeq, MiSeq, and MiniSeq, and iSeq product lines.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 September 2018 15:15:01
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB1 - 2018-09-24 16:15:01 - 2018-09-24 15:15:01 - 1000 - Website: OKAY